IL-9 regulates intestinal barrier function in experimental T cell-mediated colitis

Tissue Barriers

Volumn 3, Issue 1, 2015, Pages

  Gerlach, Katharina ^a   McKenzie, Andrew N ^b   Neurath, Markus F ^a   Weigmann, Benno ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Claudins; IL 9; Intestinal epithelial cells; Th9 cells; Tight junctions; TNBS colitis

Indexed keywords

CLAUDIN 1; CLAUDIN 4; CLAUDIN 7; INTERLEUKIN 9; OCCLUDIN; TRANSCRIPTION FACTOR PU 1; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; COLITIS; CONTROLLED STUDY; INTESTINAL BARRIER; MOUSE; NONHUMAN; NOTE; PERMEABILITY BARRIER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TH9 CELL; WESTERN BLOTTING;

EID: 84949572543     PISSN: 21688362     EISSN: 21688370     Source Type: Journal    
DOI: 10.4161/21688370.2014.983777     Document Type: Note

References (24)

1. Neurath MF, Finotto S, Glimcher LH. The role of Th1/Th2 polarization in mucosal immunity. Nat Med 2002; 8:567-73; PMID:12042806; http://dx.doi.org/10.1038/nm0602-567.
2. Fuss IJ, Neurath M, Boirivant M, Klein JS, de la Motte C, Strong SA, Fiocchi C, Strober W. Disparate CD4C lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J Immunol 1996; 157:1261-70; PMID:8757634.
3. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, Martin B, Wilhelm C, Stockinger B. Transforming growth factor-beta’reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008; 9:1341-6; PMID:18931678; http://dx.doi.org/10.1038/ni.1659.
4. Chang HC, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL, Jabeen R, McKinley C, Ahyi AN, Han L. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 2010; 11:527-34; PMID:20431622; http://dx.doi.org/10.1038/ni.1867.
5. Goswami R, Kaplan MH. A brief history of IL-9. J Immunol 2011; 186:3283-8; PMID:21368237; http:// dx.doi.org/10.4049/jimmunol.1003049.
6. Gonzalez-Mariscal L, Betanzos A, Nava P, Jaramillo BE. Tight junction proteins. Prog Biophys Mol Biol 2003; 81:1-44; PMID:12475568; http://dx.doi.org/ 10.1016/S0079-6107(02)00037-8.
7. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993; 123:1777-88; PMID:8276896; http://dx.doi.org/ 10.1083/jcb.123.6.1777.
8. Walsh SV, Hopkins AM, Nusrat A. Modulation of tight junction structure and function by cytokines. Adv Drug Deliv Rev 2000; 41:303-13; PMID:10854688; http://dx.doi.org/10.1016/S0169-409X(00)00048-X.
9. Gassler N, Rohr C, Schneider A, Kartenbeck J, Bach A, Obermuller N, Otto HF, Autschbach F, et al. Inflammatory bowel disease is associated with changes of enterocytic junctions. Am J Physiol Gastrointest Liver Physiol 2001; 281:G216-28; PMID:11408275.
10. Poritz LS, Garver KI, Green C, Fitzpatrick L, Ruggiero F, Koltun WA. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J Surg Res 2007; 140:12-9; PMID:17418867; http://dx.doi.org/ 10.1016/j.jss.2006.07.050.
11. Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, Lehr HA, Wirtz S, Vieth M, Waisman A, et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol 2014; 15:676-86; PMID:24908389; http://dx.doi.org/ 10.1038/ni.2920.
12. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117:514-21; PMID:17332878; http://dx.doi.org/10.1172/JCI30587.
13. Mitic LL, Van Itallie CM, Anderson JM. Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 2000; 279:G250-4; PMID:10915631.
14. Kirschner N, Rosenthal R, Furuse M, Moll I, Fromm M, Brandner JM. Contribution of tight junction proteins to ion, macromolecule, and water barrier in keratinocytes. J Invest Dermatol 2013; 133:1161-9; PMID:23407391; http://dx.doi.org/10.1038/jid.2012.507.
15. Schulzke JD, Ploeger S, Amasheh M, Fromm A, Zeissig S, Troeger H, Richter J, Bojarski C, Schumann M, Fromm M. Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci 2009; 1165:294-300; PMID:19538319; http://dx.doi.org/10.1111/j.1749-6632.2009.04062.x.
16. Heller F, Florian P, Bojarski C, Richter J, Christ M, Hillenbrand B, Mankertz J, Gitter AH, Bürgel N, Fromm M, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 2005; 129:550-64; PMID:16083712; http://dx.doi.org/10.1016/j.gastro.2005.05.002.
17. Das P, Goswami P, Das TK, Nag T, Sreenivas V, Ahuja V, Panda SK, Gupta SD, Makharia GK. Comparative tight junction protein expressions in colonic Crohn’s disease, ulcerative colitis, and tuberculosis: a new perspective. Virchows Arch 2012; 460:261-70; PMID:22297703; http://dx.doi.org/10.1007/s00428-012-1195-1.
18. Peeters M, Ghoos Y, Maes B, Hiele M, Geboes K, Vantrappen G, Rutgeerts P. Increased permeability of macroscopically normal small bowel in Crohn’s disease. Dig Dis Sci 1994; 39:2170-6; PMID:7924738; http:// dx.doi.org/10.1007/BF02090367.
19. Poritz LS, Harris LR, 3rd, Kelly AA, Koltun WA. Increase in the tight junction protein claudin-1 in intestinal inflammation. Dig Dis Sci 2011; 56:2802-9; PMID:21748286; http://dx.doi.org/10.1007/s10620-011-1688-9.
20. Townsend JM, Fallon GP, Matthews JD, Smith P, Jolin EH, McKenzie NA. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 2000; 13:573-83; PMID:11070175; http://dx.doi.org/10.1016/S1074-7613(00)00056-X.
21. Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007; 2:541-6; PMID:17406617; http://dx.doi.org/10.1038/nprot.2007.41.
22. Becker C, Fantini MC, Wirtz S, Nikolaev A, Kiesslich R, Lehr HA, Galle PR, Neurath MF. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut 2005; 54:950-4; PMID:15951540; http://dx.doi.org/10.1136/gut.2004.061283.
23. Gerlach K, Daniel C, Lehr HA, Nikolaev A, Gerlach T, Atreya R, Rose-John S, Neurath MF, Weigmann B. Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitis. Cancer Res 2012; 72:4340-50; PMID:22738913; http://dx.doi.org/10.1158/0008-5472.CAN-11-4155.
24. Weigmann B, Tubbe I, Seidel D, Nicolaev A, Becker C, Neurath MF. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc 2007; 2:2307-11; PMID:17947970; http://dx.doi.org/10.1038/nprot.2007.315